Ujjain Medi-Cure Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-01-2025
- Paid Up Capital ₹ 0.10 M
as on 05-01-2025
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 8.50 M
as on 05-01-2025
- Revenue %
(FY 2021)
- Profit 6.91%
(FY 2021)
- Ebitda
- Net Worth -0.08%
(FY 2021)
- Total Assets 0.03%
(FY 2021)
About Ujjain Medi-Cure Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.50 M.
Yogesh Gautam, Pramod Kaushik, Rajan Bhoraskar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110MP2004PTC016505
- Company No.
016505
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2004
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- LocationUjjain, Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ujjain Medi-Cure Hospital?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Gautam  | Director | 31-Mar-2004 | Current |
| Pramod Kaushik | Director | 31-Mar-2004 | Current |
| Rajan Bhoraskar | Director | 31-Mar-2004 | Current |
| Suresh Sharma | Director | 31-Mar-2004 | Current |
| Sharad Nayak | Director | 31-Mar-2004 | Current |
Financial Performance of Ujjain Medi-Cure Hospital.
Ujjain Medi-Cure Hospital Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.91% increase in profit. The company's net worth dipped by a decrease of 0.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ujjain Medi-Cure Hospital?
In 2021, Ujjain Medi-Cure Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ujjaini Medicare Private LimitedActive 1 year 4 months
Suresh Sharma and Sharad Nayak are mutual person
Charges (Loans)
₹8.50 M
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 0.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2004 | Icici Bank Limited | ₹8.50 M | Open |
How Many Employees Work at Ujjain Medi-Cure Hospital?
Unlock and access historical data on people associated with Ujjain Medi-Cure Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ujjain Medi-Cure Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ujjain Medi-Cure Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.